Effects of psychedelic, DOI, on nucleus accumbens dopamine signaling to predictable rewards and cues in rats
David Martin, Angel M. Delgado, Donna J. Calu
Neuropsychopharmacology July 6, 2024 DOI: 10.1038/s41386-024-01912-4 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study Peer reviewed |
|---|---|
| Population | Rats |
| Intervention | DOI |
| Dose | 0.0-1.2 mg/kg, i.p. |
| Keywords | Nucleus accumbens Dopamine |
| Citations | 3 |
| Key findings | DOI increases dopamine signals to rewards and proximal reward cues but not to distal cues, independent of reward value, indicating enhanced prediction error signaling. |
Abstract
Psychedelics produce lasting therapeutic responses in neuropsychiatric diseases suggesting they may disrupt entrenched associations and catalyze learning. Here, we examine psychedelic 5-HT2A/2C agonist, DOI, effects on dopamine signaling in the nucleus accumbens (NAc) core, a region extensively linked to reward learning, motivation, and drug-seeking. We measure phasic dopamine transients following acute DOI administration in rats during well learned Pavlovian tasks in which sequential cues predict rewards. We find that DOI (0.0-1.2 mg/kg, i.p.) increases dopamine signals, photometrically measured using GRABDA optical sensor, to rewards and proximal reward cues, but not to the distal cues that predict these events. We determine that the elevated dopamine produced by DOI to reward cues occurs independently of DOI-induced changes in reward value. The increased dopamine associated with predictable reward cues and rewards supports DOI-induced increases in prediction error signaling. These findings lay a foundation for developing psychedelic strategies aimed at engaging error-driven learning mechanisms to disrupt entrenched associations or produce new associations.